Clinical Trials Browser

Phase 3 × Non-Squamous Non-Small Cell Lung Cancer × Docetaxel × Clear all

NCT02008227 2019-12-20

OAK

Phase 3 Completed

1,225 enrolled 32 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Phase 3 Completed

485 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer